Literature DB >> 21109942

Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma.

Nijiro Nohata1, Toyoyuki Hanazawa, Naoko Kikkawa, Muradil Mutallip, Lisa Fujimura, Hirofumi Yoshino, Kazumori Kawakami, Takeshi Chiyomaru, Hideki Enokida, Masayuki Nakagawa, Yoshitaka Okamoto, Naohiko Seki.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs of approximately 22 nucleotides that can function as oncogenes or tumor suppressors in human cancer. Down-regulation of the miRNA miR-133a in many type of cancers, and a reduction of cell proliferation, migration, and invasion upon over-expression, suggests that miR-133a is a tumor suppressor. In this study, genome-wide gene expression analysis of HNSCC cells that over-express miR-133a showed that caveolin-1 (CAV1), a multifunctional scaffolding protein, is down-regulated, a result that was confirmed by real-time PCR and Western blot analysis. A luciferase reporter assay revealed that miR-133a is directly bound to CAV1 mRNA. Cancer cell migration and invasion were significantly inhibited in HNSCC cells transfected with si-CAV1. Therefore, CAV1 functions as an oncogene in HNSCC. The identification of tumor suppressive miRNAs and their target genes could provide new insights into potential mechanism of HNSCC carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21109942

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  58 in total

1.  Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy.

Authors:  Shan Wang; Xin Wen; Xin-Rui Han; Yong-Jian Wang; Min Shen; Shao-Hua Fan; Juan Zhuang; Zi-Feng Zhang; Qun Shan; Meng-Qiu Li; Bin Hu; Chun-Hui Sun; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Cell Prolif       Date:  2018-04-27       Impact factor: 6.831

2.  MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47.

Authors:  Hui Li; Yan Wang; Yan-Zhong Li
Journal:  Tumour Biol       Date:  2016-10-11

Review 3.  From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.

Authors:  Alberto Dávalos; Carlos Fernández-Hernando
Journal:  Pharmacol Res       Date:  2013-02-19       Impact factor: 7.658

Review 4.  Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview.

Authors:  Samapika Routray
Journal:  Tumour Biol       Date:  2014-08-16

5.  Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance.

Authors:  Stephanie Hehlgans; Nils Cordes
Journal:  Am J Cancer Res       Date:  2011-03-20       Impact factor: 6.166

6.  MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation.

Authors:  Catarina Rippe; Mark Blimline; Katherine A Magerko; Brooke R Lawson; Thomas J LaRocca; Anthony J Donato; Douglas R Seals
Journal:  Exp Gerontol       Date:  2011-10-15       Impact factor: 4.032

7.  MicroRNA-124 reduces caveolar density by targeting caveolin-1 in porcine kidney epithelial PK15 cells.

Authors:  Songbai Yang; Xiangdong Liu; Xinyun Li; Shufeng Sun; Fei Sun; Bin Fan; Shuhong Zhao
Journal:  Mol Cell Biochem       Date:  2013-09-03       Impact factor: 3.396

8.  Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).

Authors:  Lukman Bin Md Auzair; Vui King Vincent-Chong; Wan Maria Nabillah Ghani; Thomas George Kallarakkal; Anand Ramanathan; Chia Ee Lee; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Mannil Thomas Abraham; Rosnah Binti Zain
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-03       Impact factor: 2.503

9.  Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.

Authors:  Blanca Torrejón; Ion Cristóbal; Federico Rojo; Jesús García-Foncillas
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

Review 10.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.